Search research articles
Contact Us
Filters
Showing results (1-10 of 81) with videos related to
Page
of 9
Sort By:
La Radiologia Medica
|
October 1, 1980
[Nuclear medicine technics in the study of bone metabolic diseases]
I Fogelman, R G Bessent
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 1, 1980
What do we want from a bone-scanning agent?
I Fogelman, R G Bessent
European Journal of Nuclear Medicine
|
January 1, 1981
The effect of parathyroid hormone on technetium-99m pyrophosphate distribution in rats
I Fogelman, R G Bessent
Annals of Internal Medicine
|
August 1, 1979
Renal excretion of technetium-99m diphosphonate in osteomalacia
I Fogelman, R G Bessent
European Journal of Nuclear Medicine
|
May 15, 1998
Pulmonary embolism exclusion: a practical approach to low probability using the PIOPED data. Prospective Investigation of Pulmonary Embolism Diagnosis
H W Gray, R G Bessent
The British Journal of Radiology
|
November 1, 1974
Letter: Pitfalls in gamma camera field uniformity correction
W J Hannan, R G Bessent
British Medical Journal (Clinical Research Ed.)
|
August 1, 1987
Device to permit recapping of syringes without risk of infection
R G Bessent, R Donnet, A Shaw
European Journal of Nuclear Medicine
|
March 1, 1981
A critical assessment of bone scan quantitation (bone to soft tissue ratios) in the diagnosis of metabolic bone disease
I Fogelman, R G Bessent, D Gordon
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 1, 1981
Measurement of 24-hour whole-body retention of Tc-99m HEDP by a gamma camera
W Martin, I Fogelman, R G Bessent
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 1, 1984
Technetium-thallium subtraction images for location of parathyroid adenomata
J H McKillop, R G Bessent, I Fogelman
Page
of 9
Search research articles
Search
Showing results (1-10 of 81) with videos related to
Sort By:
Page
of 9
La Radiologia Medica
|
October 1, 1980
[Nuclear medicine technics in the study of bone metabolic diseases]
I Fogelman, R G Bessent
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 1, 1980
What do we want from a bone-scanning agent?
I Fogelman, R G Bessent
European Journal of Nuclear Medicine
|
January 1, 1981
The effect of parathyroid hormone on technetium-99m pyrophosphate distribution in rats
I Fogelman, R G Bessent
Annals of Internal Medicine
|
August 1, 1979
Renal excretion of technetium-99m diphosphonate in osteomalacia
I Fogelman, R G Bessent
European Journal of Nuclear Medicine
|
May 15, 1998
Pulmonary embolism exclusion: a practical approach to low probability using the PIOPED data. Prospective Investigation of Pulmonary Embolism Diagnosis
H W Gray, R G Bessent
The British Journal of Radiology
|
November 1, 1974
Letter: Pitfalls in gamma camera field uniformity correction
W J Hannan, R G Bessent
British Medical Journal (Clinical Research Ed.)
|
August 1, 1987
Device to permit recapping of syringes without risk of infection
R G Bessent, R Donnet, A Shaw
European Journal of Nuclear Medicine
|
March 1, 1981
A critical assessment of bone scan quantitation (bone to soft tissue ratios) in the diagnosis of metabolic bone disease
I Fogelman, R G Bessent, D Gordon
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 1, 1981
Measurement of 24-hour whole-body retention of Tc-99m HEDP by a gamma camera
W Martin, I Fogelman, R G Bessent
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 1, 1984
Technetium-thallium subtraction images for location of parathyroid adenomata
J H McKillop, R G Bessent, I Fogelman
Page
of 9